Showing results (551-560 of 1,011) with videos related to
Sort By:
Pageof 102
Stroke|June 21, 2008
Associations of proinflammatory cytokines with the risk of recurrent strokePaul Welsh, Gordon D O Lowe, John Chalmers, et al.Anaesthesia|December 18, 2025
Peri-operative pain management in major lower extremity amputation in vascular Surgery: a UK anaesthetic and vascular surgery Delphi consensus studyThanapon Ekkunagul, Caitlin Sara MacLeod, Anna Celnik, et al.International Journal of Epidemiology|September 26, 2006
Chronic diseases now a leading cause of death in rural India--mortality data from the Andhra Pradesh Rural Health InitiativeRohina Joshi, Magnolia Cardona, Srinivas Iyengar, et al.International Journal of Epidemiology|January 23, 2016
Mean population salt intake estimated from 24-h urine samples and spot urine samples: a systematic review and meta-analysisLiping Huang, Michelle Crino, Jason H Y Wu, et al.JACC. Advances|October 28, 2025
FGF-23, hsCRP, Cardiovascular Events, and the Benefit of Canagliflozin in the CANVAS TrialAranya Punithan, Ehsan Ghamarian, Daniela Grothe, et al.Nutrients|September 8, 2017
Modelled Cost-Effectiveness of a Package Size Cap and a Kilojoule Reduction Intervention to Reduce Energy Intake from Sugar-Sweetened Beverages in AustraliaMichelle Crino, Ana Maria Mantilla Herrera, Jaithri Ananthapavan, et al.BMJ Nutrition, Prevention & Health|July 26, 2021
Estimating the potential impact of Australia's reformulation programme on households' sodium purchasesDaisy Coyle, Maria Shahid, Elizabeth Dunford, et al.Stroke and Vascular Neurology|September 30, 2017
Characteristics, management and response to alteplase in China versus non-China participants of the ENCHANTED trialLily Song, Xia Wang, Thompson Robinson, et al.Diabetes Care|November 7, 2020
Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment StudyJames L Januzzi, Javed Butler, Naveed Sattar, et al.The New England Journal of Medicine|June 13, 2017
Canagliflozin and Cardiovascular and Renal Events in Type 2 DiabetesBruce Neal, Vlado Perkovic, Kenneth W Mahaffey, et al.Pageof 102